CoChat

Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2060: The SEARCH for Diabetes in Youth Study

Open access
Tönnies, Thaddäus, Brinks, Ralph, Isom, Scott, Dabelea, Dana, Divers, Jasmin, Mayer-Davis, Elizabeth J., Lawrence, Jean M., Pihoker, Catherine, Dolan, Lawrence, Liese, Angela D., Saydah, Sharon H., D’Agostino, Ralph B., Hoyer, Annika, Imperatore, Giuseppina · 2023 · Diabetes Care
Cited by 153

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To project the prevalence and number of youths with diabetes and trends in racial and ethnic disparities in the U.S. through 2060. RESEARCH DESIGN AND METHODS: Based on a mathematical model and data from the SEARCH for Diabetes in Youth study for calendar years 2002–2017, we projected the future prevalence of type 1 and type 2 diabetes among youth aged <20 years while considering different scenarios of future trends in incidence. RESULTS: The number of youths with diabetes will increase from 213,000 (95% CI 209,000; 218,000) (type 1 diabetes 185,000, type 2 diabetes 28,000) in 2017 to 239,000 (95% CI 209,000; 282,000) (type 1 diabetes 191,000, type 2 diabetes 48,000) in 2060 if the incidence remains constant as observed in 2017. Corresponding relative increases were 3% (95% CI −9%; 21%) for type 1 diabetes and 69% (95% CI 43%; 109%) for type 2 diabetes. Assuming that increasing trends in incidence observed between 2002 and 2017 continue, the projected number of youths with diabetes will be 526,000 (95% CI 335,000; 893,000) (type 1 diabetes 306,000, type 2 diabetes 220,000). Corresponding relative increases would be 65% (95% CI 12%; 158%) for type 1 diabetes and 673% (95% CI 362%; 1,341%) for type 2 diabetes. In both scenarios, substantial widening of racial and ethnic disparities in type 2 diabetes prevalence are expected, with the highest prevalence among non-Hispanic Black youth. CONCLUSIONS: The number of youths with diabetes in the U.S. is likely to substantially increase in future decades, which emphasizes the need for prevention to attenuate this trend.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc22-0945

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. Divers, 2020, Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002-2015, MMWR Morb Mortal Wkly Rep, 69, 161, 10.15585/mmwr.mm6906a3 · DOI · Paper page
  2. Lawrence, 2021, Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017, JAMA, 326, 717, 10.1001/jama.2021.11165 · DOI · Paper page
  3. Dabelea, 2018, Diabetes in youth-looking backwards to inform the future: Kelly West Award Lecture 2017, Diabetes Care, 41, 233, 10.2337/dci17-0031 · DOI
  4. Dabelea, 2017, Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood, JAMA, 317, 825, 10.1001/jama.2017.0686 · DOI · Paper page
  5. Reynolds, 2018, Mortality in youth-onset type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth study, J Diabetes Complications, 32, 545, 10.1016/j.jdiacomp.2018.03.015 · DOI · Paper page
  6. Lawrence, 2021, Demographic correlates of short-term mortality among youth and young adults with youth-onset diabetes diagnosed from 2002 to 2015: the SEARCH for Diabetes in Youth study, Diabetes Care, 44, 2691, 10.2337/dc21-0728 · DOI
  7. Hamman, 2014, The SEARCH for Diabetes in Youth study: rationale, findings, and future directions, Diabetes Care, 37, 3336, 10.2337/dc14-0574 · DOI · Paper page
  8. Brinks, 2014, Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany, Theor Popul Biol, 92, 62, 10.1016/j.tpb.2013.11.006 · DOI
  9. Tönnies, 2019, Projected number of people with diagnosed type 2 diabetes in Germany in 2040, Diabet Med, 36, 1217, 10.1111/dme.13902 · DOI · Paper page
  10. Tönnies, 2019, Estimating prevalence of type I and type II diabetes using incidence rates: the SEARCH for Diabetes in Youth study, Ann Epidemiol, 37, 37, 10.1016/j.annepidem.2019.07.006 · DOI
  11. Imperatore, 2012, Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth, Diabetes Care, 35, 2515, 10.2337/dc12-0669 · DOI · Paper page
  12. Gregg, 2016, The changing face of diabetes complications, Lancet Diabetes Endocrinol, 4, 537, 10.1016/S2213-8587(16)30010-9 · DOI · Paper page
  13. Lange, 2021, Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 2-19 years - United States, 2018-2020, MMWR Morb Mortal Wkly Rep, 70, 1278, 10.15585/mmwr.mm7037a3 · DOI · Paper page
  14. Rughani, 2020, Type 2 diabetes in youth: the role of early life exposures, Curr Diab Rep, 20, 45, 10.1007/s11892-020-01328-6 · DOI
  15. Hartz, 2018, Locations! Location! Location? Elucidating the social determinants of cardiometabolic health among United States adolescents, J Adolesc Health, 63, 519, 10.1016/j.jadohealth.2018.08.001 · DOI
  16. Hoyer, 2019, Risk factors in the illness-death model: simulation study and the partial differential equation about incidence and prevalence, PLoS One, 14, e0226554, 10.1371/journal.pone.0226554 · DOI
  17. Tönnies, 2021, Estimating the impact of tax policy interventions on the projected number and prevalence of adults with type 2 diabetes in Germany between 2020 and 2040, BMJ Open Diabetes Res Care, 9, e001813, 10.1136/bmjdrc-2020-001813 · DOI
  18. Zeitler, 2009, Update on nonautoimmune diabetes in children, J Clin Endocrinol Metab, 94, 2215, 10.1210/jc.2009-0493 · DOI
  19. Wallace, 2020, Screening and diagnosis of prediabetes and diabetes in US children and adolescents, Pediatrics, 146, e20200265, 10.1542/peds.2020-0265 · DOI · Paper page

Cited by

See all 153

Metadata

Authors
Tönnies, T., Brinks, R., Isom, S., Dabelea, D., Divers, J., Mayer-Davis, E. J., Lawrence, J. M., Pihoker, C., Dolan, L., Liese, A. D., Saydah, S. H., D’Agostino, R. B., Hoyer, A., & Imperatore, G.
Venue
Diabetes Care
Published
2022-12-29
Volume
46
Issue
2
Pages
313-320
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4313279502
Cited by
153
References
8
FWCI
18.52
Type
journal article
Language
en
Open access
green
Funders
  • Children with Medical Handicaps program managed by the Ohio Department of Health
  • Centers for Disease Control and Prevention
  • University of Colorado Denver
  • Kaiser Permanente Southern California
  • University of Colorado Pediatric Clinical and Translational Research Center, NIH/NCATS (UL1 TR000154)
  • University of Cincinnati, NIH/NCATS (UL1 TR000077, UL1 TR001425)
  • Barbara Davis Center at the University of Colorado at Denver DERC NIH (P30 DK57516)
  • Cincinnati’s Children’s Hospital Medical Center (U48/CCU519239, U01 DP000248, 1U18DP002709)
  • South Carolina Clinical & Translational Research Institute, at the Medical University of South Carolina, NIH/National Center for Advancing Translational Sciences (UL1 TR000062, UL1 Tr001450)
  • University of North Carolina at Chapel Hill (U48/CCU419249, U01 DP000254, U18DP002708)
  • National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK127208-01, 1UC4DK108173, 1U18DP006131, U18DP)
  • Kaiser Permanente Southern California’s Marilyn Owsley Clinical Research Center
  • Seattle Children’s Hospital and the University of Washington, NIH/NCATS grant number (UL1 TR00423)
  • Wake Forest University School of Medicine (U48/CCU919219, U01 DP000250, 200-2010-35171)
  • Seattle Children’s Hospital (U58/CCU019235-4, U01 DP000244, U18DP002710-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.